Ledger.Open graph →
SEC Form D · filed February 23, 2026

Lonestar Medicines, Inc

Offering
$45.0M
Sold
$25.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Naveen M. Daryani · Scotch Plains, NJExecAndrew M. Levin · Scotch Plains, NJDirectorWilliam D. Bonificio · Scotch Plains, NJExec · PromoterGianna M. Hoffman-Luca · BOSTON, MADirectorStephen B. Thomas · Scotch Plains, NJExec · Director · Promoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗